Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk - Richard, S; Chari, A; Delimpasi, S; Simonova, M; Spicka, I; Pour, L; Kriachok, I; Dimopoulos, MA; Pylypenko, H; Auner, HW; Leleu, X; Usenko, G; et al. (AMERICAN JOURNAL OF HEMATOLOGY, 2021)